ICU Stock Overview
A medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
SeaStar Medical Holding Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.80 |
| 52 Week High | US$42.92 |
| 52 Week Low | US$1.50 |
| Beta | -0.99 |
| 1 Month Change | -9.55% |
| 3 Month Change | -32.58% |
| 1 Year Change | -92.00% |
| 3 Year Change | -99.28% |
| 5 Year Change | n/a |
| Change since IPO | -99.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| ICU | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -21.1% | -0.3% | -0.3% |
| 1Y | -92.0% | 12.5% | 20.2% |
Return vs Industry: ICU underperformed the US Medical Equipment industry which returned 12.5% over the past year.
Return vs Market: ICU underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| ICU volatility | |
|---|---|
| ICU Average Weekly Movement | 15.9% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 18.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ICU's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ICU's weekly volatility has decreased from 21% to 16% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 12 | Eric Schlorff | www.seastarmedical.com |
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.
SeaStar Medical Holding Corporation Fundamentals Summary
| ICU fundamental statistics | |
|---|---|
| Market cap | US$8.75m |
| Earnings (TTM) | -US$29.87m |
| Revenue (TTM) | US$68.00k |
118.1x
P/S Ratio-0.3x
P/E RatioIs ICU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICU income statement (TTM) | |
|---|---|
| Revenue | US$68.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$68.00k |
| Other Expenses | US$29.94m |
| Earnings | -US$29.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.69 |
| Gross Margin | 100.00% |
| Net Profit Margin | -43,923.53% |
| Debt/Equity Ratio | 0% |
How did ICU perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/10 00:06 |
| End of Day Share Price | 2025/02/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SeaStar Medical Holding Corporation is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anthony Vendetti | Maxim Group |